Navigation Links
M. D. Anderson nurse addresses lymphedema in breast cancer patients and survivors
Date:5/17/2008

PHILADELPHIA - A poster session presented today by The University of Texas M. D. Anderson Cancer Center at the Oncology Nurses Society 33rd Annual Congress, found that early nursing intervention and implementation of effective strategies can lead to a decrease in the incidence of lymphedema, better management of chronic lymphedema and improved quality of life in breast cancer patients.

The literature review, led by Mattie J. Sennett McDowell, RN, BSN, a research nurse in the Department of Breast Medical Oncology at M. D. Anderson, examined 20 years of data about the prevention, management and care of upper extremity lymphedema (ULE), or lymphedema that occurs in the arms, in breast cancer patients. The goal of the review was to identify a comprehensive list of current evidenced-based strategies that nurses and hospitals can use in caring for their patients.

"Women are living longer as breast cancer treatments get better, but at the same time, they face more devastating side effects like lymphedema," McDowell said. "So many women present with the symptoms, yet it is understudied and not well understood. More can to be done to proactively recognize and address lymphedema in breast cancer patients."

ULE is an often a distressing and debilitating side effect of breast cancer treatment in which protein-rich fluid in the tissue of the arms accumulates and obstructs the lymph vessels. According to the National Lymphedema Network, approximately 15 to 20 percent of all breast cancer patients are affected by ULE. Its development can be triggered by breast cancer diagnostic procedures, radiation, surgery or environmental factors. It also can can occur immediately after treatment or many years down the road. ULE, which can make simple tasks such as picking up children, getting dressed or exercising painful, has a detrimental impact on the patient's quality of life.

According to the literature, effective strategies to address lymphedema included early identification of at-risk patients through enhanced assessment techniques, monitoring, standardizing at-risk assessment tools and increased awareness of lymphedema through educational efforts of the health care team. The studies noted that increased awareness through educational forums, patient-nurse learning modules, and increasing the number of research studies focusing on ULE are vital in addressing this problem.

McDowell, who is dedicated to the study, prevention and management of ULE after a breast cancer patient died from significant disease progression, complicated by advanced, unmanageable lymphedema, said, "This research is centered on what is important to the patient and their quality of life after treatment. Nurses are on the frontline and may hold the key in proactively preventing lymphedema in many patients by educating them about triggers and symptoms, continual and specific lymphedema assessments during each visit and pursuing research in this area."

At M. D. Anderson, nurses and patient care teams have implemented several strategies to educate breast cancer patients about lymphedema and treat it aggressively. One such strategy is having a nurse and physician present information via discussion and prepared handouts before women undergo surgery. Additionally, all women are assessed for lymphedema during treatment and at follow-up visits. M. D. Anderson's multidisciplinary care team also offers comprehensive support and collaboration from prevention of the sequelae to advanced physical therapy for those with lymphedema.

McDowell plans to develop further research studies examining the evidenced-based practices for ULE identified in this study, with the end-goal of developing a standard set of recommendations. More information on the causes and symptoms of lymphedema, risk reduction strategies and recommended treatment are provided online at M. D. Anderson's Rehabilitation Services Lymphedema homepage or by logging onto the National Lymphedema Network Web site.


'/>"/>

Contact: Julie A. Penne
jpenne@mdanderson.org
281-460-1788
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Related medicine news :

1. M.D. Anderson-led team reports possible key to autoimmune disease
2. UCI Medical Affiliates Inc. Opens a New Doctors Care Center in Anderson
3. M. D. Anderson-Prevention poll finds women can do more to prevent cancer...but arent
4. M. D. Anderson-Prevention poll finds women can do more to prevent cancer ... but arent
5. M. D. Anderson researchers identify tumor-suppressor gene for lung cancer
6. SEIU Endorses Anderson, Perea, and Perea in Fresno
7. M. D. Anderson research links diet, gardening and lung cancer risk
8. CyberKnife Centers of Miami, Palm Beach and Tampa Invited to Join M.D. Anderson Cancer Center Study
9. Naviscan PET Systems to Place High-Resolution PET Scanner at M. D. Anderson Cancer Center
10. M. D. Anderson nurses find empowerment in PACTs
11. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... AMC Health , the leading provider ... the clinical trials market. Similar to its approach in demonstrating positive outcomes in the ... marketplace by proving the value of eVisits to support virtual studies. , ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... in Cincinnati, OH for leading-edge care, whether or not they have a referral. ... the BIOLASE WaterLase® iPlus™ laser, she targets bacteria and damaged tissue without affecting ...
(Date:6/20/2017)... JEFFERSON HILLS, PA (PRWEB) , ... June 20, ... ... now available at Allegheny Health Network’s (AHN) Jefferson Hospital is providing physicians with ... 1.5T, 48-channel scanner provides higher-resolution images than traditional MRIs, enabling doctors to get ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... SweetLeaf® Stevia Sweetener, Michael P. May, Ph.D., recently accepted the distinguished Sun Corridor ... Program selected Wisdom Natural Brands (WNB), and 16 other businesses from Pima, Pinal, ...
(Date:6/20/2017)... ... 20, 2017 , ... BrightStar Care Centerville/South Dayton, a home ... Joint Commission, which accredits and certifies nearly 21,000 healthcare organizations and programs in ... symbol of quality that reflects an organization’s commitment to meeting certain performance standards. ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
(Date:5/30/2017)... May 30, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... Global Healthcare Conference on Tuesday, June 13, 2017, in ... , Hill-Rom,s president and chief executive officer, is scheduled to ... audio webcast can be accessed at http://ir.hill-rom.com/events.cfm . A ... the live event through September 13, 2017. ...
Breaking Medicine Technology: